Glioblastoma is an aggressive form of brain tumour. It has a highly innovative therapy pipeline with 120 first-in-class programmes, according to a new report from GBI...

Laboratory instruments and solutions provider Tecan Group has announced its decision to acquire sample preparation solutions provider SPEware Corporation for...

PaxVax Inc and Seqirus Inc have entered a marketing and distribution...

Entry of a range of new companies is set to double the growth of the ophthalmological disorders market from $13.7bn in 2015 to $26bn by 2022, according to a report from GBI...

OraSure Technologies and the US Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response’s Biomedical Advanced Research and...

Tiger X Medical has announced a merger with Biocardia Inc to advance development of CardiAMP cell therapy system to treat heart failure....

Medical Marijuana Inc and CannaNative LLC have entered a partnership to produce a cannabis product line and supply them to more than 560 US tribal...

Improved treatment options to cover unmet needs of rheumatoid arthritis patients can be provided by first-in-class product innovation, states a new report from GBI...

Scintilla Pharmaceuticals has entered a binding term sheet to acquire Semnur Pharmaceuticals for a purchase consideration of up to...

Selvita Inc and University of California, San Francisco (UCSF) have entered an agreement to further develop therapeutics with pharmacological properties for neurodegenerative...

Biotechnology company Guanhao Biotech has announced its acquirement of a 5% stake within a pharmaceutical company based in Beijing,...

The acute coronary syndrome (ACS) market is projected to grow beyond $12bn by 2022 at a compound annual growth rate of 4.6% steered by the launch of new lipid-targeting therapies, says a...

Natera INC. and University of California, San Francisco (UCSF) have entered a research agreement to analyse and study the DNA markers of kidney transplant...

An increase in sales within the venous thromboembolism (VTE) primary prophylaxis space is expected to drive the growth in the VTE market from $2.8bn in 2015 to $3.7bn by 2025, according to a...

BTC Network has acquired Novex Clinical Research LLC, to strengthen its expertise and commitment in therapeutic areas such as psychiatry, neurology, pain and internal...

Luye Pharma Group Ltd has announced its acquirement of the entire issued share capital of Acino AG and Acino Supply AG for a purchase consideration of...

AbbVie has entered a clinical trial agreement with Bristol-Myers Squibb Company to evaluate the safety and efficacy of the former’s Rova-T, as well as in combination with the latter’s Opdivo,...

The stem cell therapies market faces several obstacles that slow the wider application of stem cells for treatment purposes, according to a report by GBI Research. Despite possessing a...

Biopharmaceutical company Hansa Medical AB has acquired Immago Biosystems Ltd, a therapeutic antibodies developer in...

T2 Biosystems and Bayer AG have entered a multi-year research and development (R&D) agreement to further research on the T2 Magnetic Resonance technology (T2MR) with haemostasis drug...

Seres Therapeutics and Emulate have entered an agreement to advance the drug discovery for inflammatory bowel disease and other serious...